Evidence map›Paper›PMID 26321142›Full record

ArticleStem cell reports2015

Preferential Propagation of Competent SIX2+ Nephronic Progenitors by LIF/ROCKi Treatment of the Metanephric Mesenchyme.

Shunsuke Tanigawa, Nirmala Sharma, Michael D Hall, Ryuichi Nishinakamura, Alan O Perantoni

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Dynamic Kidney Organoid Microphysiological Analysis Platform.bioRxiv : the preprint server for biology · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Epigenetic regulation of kidney progenitor cells.Stem cells translational medicine · 2020
    Review
  11. Review
  12. Article
  13. Article
  14. Recapitulating kidney development: Progress and challenges.Seminars in cell & developmental biology · 2019
    Review
  15. Loss ofAmerican journal of physiology. Renal physiology · 2019
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shunsuke TanigawaNational Cancer Institute-Frederick, Frederick, MD 21702, USA; Department of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, 2-2-1 Honjo, Kumamoto 860-0811, Japan; Program for Leading Graduate Schools, Health Life Science: Interdisciplinary and Glocal (Global and Local) Oriented Program, Kumamoto University, 2-2-1 Honjo, Kumamoto 860-0811, Japan.
Nirmala SharmaNational Cancer Institute-Frederick, Frederick, MD 21702, USA.
Michael D HallNational Cancer Institute-Frederick, Frederick, MD 21702, USA.
Ryuichi NishinakamuraDepartment of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, 2-2-1 Honjo, Kumamoto 860-0811, Japan; Program for Leading Graduate Schools, Health Life Science: Interdisciplinary and Glocal (Global and Local) Oriented Program, Kumamoto University, 2-2-1 Honjo, Kumamoto 860-0811, Japan.
Alan O PerantoniNational Cancer Institute-Frederick, Frederick, MD 21702, USA. Electronic address: perantoa@mail.nih.gov.
Frederick National Laboratory for Cancer Research · USNational Cancer Institute · US

Funding

GrowthDifferentiation Factors in OrganogenesisZIABC005093 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI PERANTONI, ALAN · 2009 to 2019
$11.0M
Intramural NIH HHS
6 · The paper itself

Abstract

Understanding the mechanisms responsible for nephrogenic stem cell preservation and commitment is fundamental to harnessing the potential of the metanephric mesenchyme (MM) for nephron regeneration. Accordingly, we established a culture model that preferentially expands the MM SIX2+ progenitor pool using leukemia inhibitory factor (LIF), a Rho kinase inhibitor (ROCKi), and extracellular matrix. Passaged MM cells express the key stem cell regulators Six2 and Pax2 and remain competent to respond to WNT4 induction and form mature tubular epithelia and glomeruli. Mechanistically, LIF activates STAT, which binds to a Stat consensus sequence in the Six2 proximal promoter and sustains SIX2 levels. ROCKi, on the other hand, attenuates the LIF-induced differentiation activity of JNK. Concomitantly, the combination of LIF/ROCKi upregulates Slug expression and activates YAP, which maintains SIX2, PAX2, and SALL1. Using this novel model, our study underscores the pivotal roles of SIX2 and YAP in MM stem cell stability.

Indexed as

AnimalsHomeodomain ProteinsLeukemia Inhibitory FactorMesenchymal Stem CellsMiceNephronsPAX2 Transcription FactorProtein Kinase Inhibitorsrho-Associated KinasesSnail Family Transcription FactorsTranscription FactorsHomeodomain ProteinsLeukemia Inhibitory FactorLif protein, mousePax2 protein, mousePAX2 Transcription FactorProtein Kinase Inhibitorsrho-Associated KinasesSall1 protein, mouseSix2 protein, mouseSnai2 protein, mouseSnail Family Transcription FactorsTranscription Factors

Identifiers

PMID26321142
PMCPMC4618653
OpenAlexW2168390990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.